When physicist Alex Zhavoronkov looked in the mirror one day and saw alarming swelling around his eyes, he guessed it was an allergic reaction to a drug he’d taken. But he couldn’t just ring up his doctor and ask — the drug was one his own company was developing, and he was its first guinea pig.
As CEO of biotech company Insilico Medicine, Zhavoronkov routinely subjects himself to his own medicine.
